Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Intangibles (2016 - 2025)

Utah Medical Products has reported Intangibles over the past 16 years, most recently at $840000.0 for Q4 2025.

  • Quarterly results put Intangibles at $840000.0 for Q4 2025, down 98.44% from a year ago — trailing twelve months through Dec 2025 was $840000.0 (down 98.44% YoY), and the annual figure for FY2025 was $840000.0, down 98.44%.
  • Intangibles for Q4 2025 was $840000.0 at Utah Medical Products, down from $1.4 million in the prior quarter.
  • Over the last five years, Intangibles for UTMD hit a ceiling of $56.5 million in Q1 2021 and a floor of $840000.0 in Q4 2025.
  • Median Intangibles over the past 5 years was $35.4 million (2021), compared with a mean of $30.2 million.
  • Biggest five-year swings in Intangibles: surged 893.58% in 2024 and later crashed 98.44% in 2025.
  • Utah Medical Products' Intangibles stood at $2.2 million in 2021, then skyrocketed by 290.37% to $8.6 million in 2022, then skyrocketed by 528.79% to $54.3 million in 2023, then decreased by 0.97% to $53.8 million in 2024, then crashed by 98.44% to $840000.0 in 2025.
  • The last three reported values for Intangibles were $840000.0 (Q4 2025), $1.4 million (Q3 2025), and $2.0 million (Q2 2025) per Business Quant data.